cyclosporine has been researched along with Graft Occlusion, Vascular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirsch, GM; Jordan, JL; Lee, TD | 1 |
| Czer, LS; Kamlot, A; Luthringer, D; Quartel, A; Soukiasian, HJ; Trento, A; Wang, C; Wang, HM | 1 |
| Breckenridge, C; Gault, MH; Harnett, J; Longerich, LL; Purchase, L | 1 |
| Engelschalk, C; Meiser, B; Reichart, B; Seidel, D; Thiery, J; Wenke, K | 1 |
| Arndtz, N; Meiser, B; Reichart, B; Seidel, D; Thiery, J; von Scheidt, W; Wenke, K | 1 |
| Libby, P; Schoen, FJ; Sukhova, G; Swanson, SJ; Tanaka, H | 1 |
| Berry, GJ; Billingham, ME; Gregory, CR; Huang, X; Morris, RE; Rowan, R; Shorthouse, R | 1 |
| Evancho, MM; Hirko, MK; McShannic, JR; Schmidt, SP; Sharp, WV; Siebert, JD; Sims, RL | 1 |
| Boffa, GM; Bortolotti, U; Faggian, G; Livi, U; Luciani, GB; Mazzucco, A; Thiene, G | 1 |
| Douville, Y; Guidoin, R; Marois, Y; Roy, R; Wagner, E | 1 |
| Casaccia, M; di Summa, M; Marra, S; Mollo, F; Papandrea, C; Passarino, G; Pucci, A | 1 |
| Bracchi, M; Brunori, G; Gaggia, P; Gaggiotti, M; Maiorca, R; Sandrini, S | 1 |
| Follath, F; Gallino, A; Kaski, JC; Kiowski, W; Tousoulis, D; Turina, M; Vassalli, G | 1 |
| Addicks, K; Berwanger, C; Lepidi, S; Schmitz-Rixen, T; van Swyndregt, AD | 1 |
1 review(s) available for cyclosporine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Arterial hypertension in renal transplantation.
Topics: Animals; Antihypertensive Agents; Cyclosporine; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Steroids | 1996 |
3 trial(s) available for cyclosporine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia.
Topics: Cyclosporine; Fibrinogen; Graft Occlusion, Vascular; Heart Transplantation; Heparin; Humans; Hypercholesterolemia; Lipoprotein(a); Lipoproteins, LDL; Pilot Projects; Plasmapheresis | 1995 |
Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
Topics: Adult; Coronary Disease; Cyclosporine; Female; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Topics: Adult; Biopsy; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Transplantation, Homologous | 1996 |
10 other study(ies) available for cyclosporine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
Topics: Administration, Oral; Animals; CD8-Positive T-Lymphocytes; Chronic Disease; Combined Modality Therapy; Cordyceps; Cyclosporine; Drug Synergism; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Lymphocyte Culture Test, Mixed; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Rats; Rats, Inbred Lew; Transplantation, Homologous | 2008 |
Inhibition of graft coronary arteriosclerosis after heart transplantation.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Models, Animal; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Tunica Intima; Tunica Media | 2004 |
Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Child; Cholesterol; Cyclosporine; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Gemfibrozil; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Isoenzymes; Kidney; Kidney Function Tests; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Radioimmunoassay; Reference Values; Renal Dialysis; Triglycerides; Ultrasonography | 1995 |
Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.
Topics: Animals; Cell Division; Coronary Artery Disease; Cyclosporine; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Muscle, Smooth, Vascular; Rabbits; Time Factors | 1995 |
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Occlusion, Vascular; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus; Tunica Intima | 1995 |
Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Cilazapril; Cyclosporine; Dogs; Female; Femoral Artery; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Male; Time Factors; Tunica Intima; Vascular Patency | 1993 |
Clinical results of steroid-free induction immunosuppression after heart transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Female; Graft Occlusion, Vascular; Graft Rejection; Heart; Heart Transplantation; Humans; Immunosuppression Therapy; Infant; Male; Middle Aged; Muromonab-CD3; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome | 1993 |
Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil.
Topics: Animals; Blood Vessel Prosthesis; Cyclosporine; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Femoral Vein; Graft Occlusion, Vascular; Graft Rejection; Immunosuppressive Agents; Male; Microscopy, Electron, Scanning; Mycophenolic Acid; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Vascular Patency | 1995 |
Pathologic changes in a long-term heterotopic heart transplant survivor.
Topics: Coronary Disease; Cyclosporine; Fatal Outcome; Graft Occlusion, Vascular; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Transplantation, Heterotopic | 1995 |
[Causes of subintimal hyperplasia in organ transplantation].
Topics: Animals; Aorta, Abdominal; Cyclosporine; Fibromuscular Dysplasia; Graft Occlusion, Vascular; Graft Rejection; Leukocyte Count; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Tunica Intima; Tunica Media | 1992 |